72,234 articles
Methotrexate
Methotrexate (MTX, amethopterin) is an antifolate antimetabolite inhibiting dihydrofolate reductase, used for ALL and other cancers, rheumatoid arthritis, psoriasis, and ectopic pregnancy; approved in the US for cancer in 1955.
Methotrexate and prednisone combination therapy
Methotrexate and prednisone combination therapy pairs methotrexate with prednisone so prednisone controls inflammatory symptoms while methotrexate builds its effect, used mainly in early rheumatoid arthritis and giant-cell arteritis.
Methotrexate and vinblastine regimen
The methotrexate and vinblastine regimen is a two-drug intravenous chemotherapy combination used mainly for advanced urothelial carcinoma and desmoid-type fibromatosis, and forms the backbone of MVAC.
Methotrexate regimen
A methotrexate regimen is a dosing protocol for the antifolate drug methotrexate, given alone or with other agents to treat cancers, rheumatoid arthritis, and psoriasis, with doses spanning several thousand-fold.
Methotrexate toxicity
Methotrexate toxicity (ORPHA:565782) is a rare intoxication from the antifolate methotrexate: renal tubular crystal injury causing acute kidney injury, plus myelosuppression, mucositis, and hepatotoxicity, managed with leucovorin and glucarpidase.
Methotrexate-associated lymphoproliferative disorders
Methotrexate-associated lymphoproliferative disorders (MTX-LPD, OIIA-LPD) are EBV-related lymphoid proliferations or lymphomas arising in autoimmune disease patients on methotrexate, often regressing after drug withdrawal.
Methoxychlor
Methoxychlor (DMDT, Marlate, Metox), CAS 72-43-5, an organochlorine DDT-analog insecticide registered in 1948, estrogenic via the metabolite HPTE, banned in the US in 2003 and not approved in the EU.
Methoxyfenozide
Methoxyfenozide (Intrepid, Prodigy) is a diacylhydrazine ecdysone-agonist insecticide, discovered 1990 by Rohm and Haas, controlling lepidopteran larvae via premature lethal molt; EU approval expired and it was deleted from the approved list in 2026.
Methoxyflurane
Methoxyflurane (Penthrane, Penthrox, green whistle) is a volatile fluorinated hydrocarbon anesthetic introduced in 1960, withdrawn for anesthesia by the late 1970s over fluoride-mediated nephrotoxicity, and now used as a self-administered 3 mL inhaled analgesic in Australasia and Europe.
Methsuximide
Methsuximide (Celontin), an anticonvulsant succinimide chemically known as N,2-dimethyl-2-phenylsuccinimide, treats absence seizures refractory to other drugs; FDA-approved 1957 by Parke-Davis, active via N-desmethylmethsuximide metabolite.
Methuselah (lungfish)
Methuselah is an Australian lungfish (Neoceratodus forsteri) at Steinhart Aquarium, San Francisco, since November 1938; DNA dating puts her at 93 ± 9 years, the world's oldest living aquarium fish.
Methyclothiazide
Methyclothiazide (Enduron, Aquatensen) is a thiazide diuretic and sodium chloride symporter inhibitor for hypertension and edema, about 100 times more potent per mg than chlorothiazide, excreted unchanged in urine; US products are discontinued.
Methyl isothiocyanate
Methyl isothiocyanate (MITC, CAS 556-61-6), active biocide released in soil by metam sodium, metam potassium, and dazomet fumigants; broad-spectrum pre-plant soil fumigant against fungi, nematodes, insects, and weeds, and a methyl bromide alternative.
Methyl parathion
Parathion methyl (methyl parathion, CAS 298-00-0) is a Toxicity Category I organophosphate insecticide and acaricide introduced in 1949, used mainly on cotton; it inhibits acetylcholinesterase via methyl paraoxon and is restricted in the US and unapproved in the EU.
Methyl trans 6 nonenoate
Methyl trans-6-nonenoate, EU ID 226, an unsaturated methyl ester once registered as an EU pesticide attractant (AT); non-included in Annex I by Decision 2004/129/EC, not approved, default MRL 0.01 mg/kg.
Methyl-coenzyme M reductase
Methyl-coenzyme M reductase (MCR, EC 2.8.4.1), the nickel-F430 archaeal enzyme catalyzing methane formation in methanogenesis and reverse methane oxidation in ANME; structure, mechanism, isoenzymes, and biotechnology.
Methyl-CpG binding domain sequencing
Methyl-CpG binding domain sequencing, or MBD-Seq, is an epigenomic sequencing method that captures methylated DNA fragments with MBD2 proteins to map 5-methylcytosine across the genome, favoring CpG-dense regions.
Methyl-CpG-binding domain protein 4
MBD4 (MED1, methyl-CpG-binding domain protein 4) is a human DNA glycosylase with an N-terminal methyl-CpG-binding domain and C-terminal HhH glycosylase domain that repairs G:T/G:U mismatches at CpG sites; its loss causes CpG>TpG hypermutation and a recessive tumor predisposition syndrome.
Methylated DNA immunoprecipitation
Methylated DNA immunoprecipitation (MeDIP) is an antibody-based method that enriches methylated DNA fragments for methylation analysis, first reported in Nature Genetics in 2005 and widely used with sequencing as MeDIP-seq.
Methylated DNA immunoprecipitation sequencing
Methylated DNA immunoprecipitation sequencing, known as MeDIP-Seq, is an epigenomic method reported in 2008 that enriches methylated DNA fragments with an antibody and sequences them to map DNA methylation across a genome.
Methylated RNA immunoprecipitation sequencing
Methylated RNA immunoprecipitation sequencing, also called MeRIP-seq or m6A-seq, is an antibody-based method that maps N6-methyladenosine across the transcriptome by high-throughput sequencing, reporting methylated regions roughly 100 to 200 nucleotides wide rather than single sites.
Methylated-DNA-[protein]-cysteine S-methyltransferase, DNA binding
Methylated-DNA-[protein]-cysteine S-methyltransferase, DNA binding (IPR014048, PF01035) is the C-terminal helix-turn-helix DNA-binding domain of AGT/MGMT/OGT, the suicide DNA repair enzyme that removes O6-alkyl groups from guanine via Cys145.
Methylation
Methylation: addition of a methyl group, in biology catalyzed by SAM-dependent methyltransferases acting on DNA (5mC), RNA (m6A, m5C), histones, and proteins; basis of epigenetics and target of azacitidine, decitabine.
Methylation sequencing
Methylation sequencing determines which cytosines in a genome carry a methyl mark, typically by bisulfite conversion before sequencing, and reports per-cytosine methylation fractions at single-base resolution genome-wide.
Methylation-sensitive restriction enzyme sequencing
Methylation-sensitive restriction enzyme sequencing (MRE-seq) is a DNA methylation profiling method that digests DNA with enzymes cutting only unmethylated CpG sites, mapping methylation genome-wide from read coverage without bisulfite conversion.
Methylation-specific PCR
Methylation-specific PCR (MSP) is a bisulfite-conversion PCR assay that detects methylated alleles at CpG island loci, introduced in 1996 and the most common clinical technique for detecting aberrant DNA methylation.
Methyldopa
Methyldopa (alpha-methyldopa, Aldomet) is a centrally acting antihypertensive prodrug converted to alpha-methylnorepinephrine, an alpha-2 agonist. Developed in the 1950s, now used mainly for hypertension in pregnancy; causes sedation and depression.
Methylene blue
Methylene blue, a phenothiazine dye synthesized by Caro in 1876, is the standard antidote for methemoglobinemia (1 mg/kg IV), a stain, and an investigational NO-cGMP inhibitor in vasodilatory shock with unproven mortality benefit.
Methylenebisthiocyanate
Methylenebisthiocyanate (MBT, methylene dithiocyanate, CAS 6317-18-6) is an organosulfur biocide used against slime-forming bacteria, fungi, and algae in cooling water, paper mills, and wood treatment; first US-registered 1949, not EU-approved for product-type 12.
Methylenedioxypyrovalerone
Methylenedioxypyrovalerone (MDPV) is a pyrrolidinophenone synthetic cathinone stimulant from bath salts; a potent DAT/NET uptake blocker, more reinforcing than cocaine in animals, Schedule II internationally.